Ilona Reischl/LinkedIn
Nov 14, 2025, 03:17
Ilona Reischl Shared a New Article About Wiskott-Aldrich Syndrome
Ilona Reischl, Chair Committee for Advanced Therapies at European Medicines Agency, shared a post on LinkedIn:
“Another ATMP approved!”
Ttile: First gene therapy to treat rare disease Wiskott-Aldrich syndrome
Read full paper here.
Stay updated with Hemostasis Today.
-
Apr 16, 2026, 08:58Chittal Raulji: ASH-ISTH 2026 Guidelines for Anticoagulant Prophylaxis for Pediatric VTE Is Now Live in Blood Advances
-
Apr 16, 2026, 08:47Wolfgang Miesbach: Key Open Questions and Clinical Paradoxes in ITP
-
Apr 16, 2026, 08:19M Rafiqul Islam: Post-Thrombectomy Blood Pressure Management in Acute Ischemic Stroke
-
Apr 16, 2026, 06:58Rob Maloney: From Past to Progress in Hemophilia Care in the Dominican Republic
-
Apr 16, 2026, 06:51Michael Ertl: Patient-Reported Outcomes Reveal Differences in Perceived Stroke Recovery
-
Apr 16, 2026, 06:40Susan Shea: Real-Time Platelet Function Assessment in Trauma Patients
-
Apr 16, 2026, 06:36Alan Nurden: Structural Complexity of Contact Sites within Platelet Aggregates
-
Apr 16, 2026, 06:29Aaron Rodriguez Calienes: Grateful to Receive 2nd Consecutive DeSousa Award in Stroke and Interventional Research
-
Apr 16, 2026, 06:24Paul Bolaji: A Growing Movement to Transform Stroke Care in Africa